Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group

Blood (2018) 132 (15): 1584–1592.

https://doi.org/10.1182/blood-2018-05-849059

Published: 2018

Includes: Supplemental data

Journal Articles

The miRNA-193 Family Is a Potent Tumor-Suppressor and a Biomarker for Poor Prognosis in Acute Myeloid Leukemia

Blood (2016) 128 (22): 1534.

https://doi.org/10.1182/blood.V128.22.1534.1534

Published: 2016

Journal Articles

Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

Blood (2016) 127 (11): 1387–1397.

https://doi.org/10.1182/blood-2015-09-669937

Published: 2016

Includes: Supplemental data

Journal Articles

IKZF1 deletions in Pediatric Acute Myeloid Leukemia

Jasmijn de Rooij, MD, Eva Beuling, PhD, C. Michel Zwaan, Askar Obulkasim, André Baruchel, MD, Jan Trka, MD PhD, Dirk Reinhardt, MD PhD, Edwin Sonneveld, PhD, Brenda Gibson, Martin Zimmermann, Rob Pieters, MD PhD, Marry van den Heuvel-Eibrink, MD PhD, Maarten Fornerod, PhD

Blood (2014) 124 (21): 2346.

https://doi.org/10.1182/blood.V124.21.2346.2346

Published: 2014

Journal Articles

ETV6 Aberrations Are a Recurrent Event in Pediatric Acute Myeloid Leukemia with Poor Clinical Outcome

Jasmijn de Rooij, MD, Eva Beuling, PhD, Maarten Fornerod, PhD, Askar Obulkasim, André Baruchel, MD, Jan Trka, MD, PhD, Prof., Dirk Reinhardt, MD PhD, Edwin Sonneveld, PhD, Martin Zimmermann, Rob Pieters, MD PhD, Marry van den Heuvel-Eibrink, MD PhD, C. Michel Zwaan, MD PhD

Blood (2014) 124 (21): 1012.

https://doi.org/10.1182/blood.V124.21.1012.1012

Published: 2014

Journal Articles

Microrna-106b~25 Cluster Is Involved in Relapsed MLL -Rearranged Pediatric AML

Lonneke Verboon, Maarten Fornerod, PhD, Askar Obulkasim, Edwin Sonneveld, PhD, André Baruchel, MD, Jan Trka, MD PhD, Dirk Reinhardt, MD PhD, Rob Pieters, MD PhD, Jacqueline Cloos, PhD, Gertjan JL Kaspers, MD PhD, Jan-Henning Klusmann, MD, C. Michel Zwaan, MD PhD, Marry van den Heuvel-Eibrink, MD PhD

Blood (2014) 124 (21): 1038.

https://doi.org/10.1182/blood.V124.21.1038.1038

Published: 2014

Journal Articles

Clinical Impact of Additional Cytogenetic Aberrations and Complex Karyotype In Pediatric 11q23/ MLL -Rearranged AML: Results from an International Retrospective Study

Blood (2010) 116 (21): 762.

https://doi.org/10.1182/blood.V116.21.762.762

Published: 2010

Journal Articles

High IGSF4 expression In Pediatric Acute Monoblastic Leukemia with t(9;11)

Eva A Coenen, MD, Jenny Kuipers, Brian V Balgobind, Jan Stary, Andre Baruchel, Valerie de Haas, Evelina S. De Bont, MD, PhD, Dirk Reinhardt, MD, PhD, Gertjan J. Kaspers, MD, PhD, Jacqueline Cloos, Astrid Danen-van Oorschot, Monique L. Den Boer, Rolf Marschalek, Claus Meyer, Rob Pieters, MD, PhD, Christian M. Zwaan, MD, PhD, Marry van den Heuvel-Eibrink

Blood (2010) 116 (21): 3614.

https://doi.org/10.1182/blood.V116.21.3614.3614

Published: 2010

Journal Articles

Refractory Cytopenia In Childhood (RCC) with Normal Karyotype Is Unlikely to Progress to Advanced MDS Under a Watch and Wait Strategy

Shinsuke Hirabayashi, Brigitte Strahm, Stephan Schwarz, Marco Zecca, Markus Schmugge, Michael Dworzak, Marry van den Heuvel-Eibrink, Henrik Hasle, Barbara De Moerloose, Jan Stary, Dorota Wojcik, Ingrid Furlan, Franco Locatelli, Irith Baumann, Charlotte M Niemeyer

Blood (2010) 116 (21): 4007.

https://doi.org/10.1182/blood.V116.21.4007.4007

Published: 2010

Journal Articles

HOXA9 is required for survival in human MLL -rearranged acute leukemias

Joerg Faber, Andrei V. Krivtsov, Matthew C. Stubbs, Renee Wright, Tina N. Davis, Marry van den Heuvel-Eibrink, Christian M. Zwaan, Andrew L. Kung, Scott A. Armstrong

Blood (2009) 113 (11): 2375–2385.

https://doi.org/10.1182/blood-2007-09-113597

Published: 2009

Includes: Supplemental data

Journal Articles

A Complex Karyotype but Not Monosomy 7 Is an Independent Prognostic Factor in Advanced Childhood MDS.

Gudrun Gohring, Kyra Michalova, Berna Beverloo, David Betts, Jochen Harbott, Oskar Haas, Gitte Kerndrup, Laura Sainati, Eva Bergstraesser, Henrik Hasle, Jan Starý, Monika Trebo, Marry van den Heuvel-Eibrink, Marco Zecca, Alexandra Fischer, Peter Noellke, Franco Locatelli, Brigitte Schlegelberger, Charlotte M. Niemeyer

Blood (2007) 110 (11): 2452.

https://doi.org/10.1182/blood.V110.11.2452.2452

Published: 2007

Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) after a Myeloablative Conditioning Regimen in Children with Refractory Cytopenia (RC): Results of a Retrospective Analysis from the EWOG-MDS Group.

Franco Locatelli, Peter Noellke, Alexandra Fisher, Peter Bader, Maria Ester Bernardo, Eva Bergstraesser, Henrik Hasle, Marry van den Heuvel-Eibrink, Elisabeth Korthof, Jan Stary, Brigitte Strahm, Felix Zintl, Petr Sedlacek, Marco Zecca, Charlotte M. Niemeyer

Blood (2007) 110 (11): 251.

https://doi.org/10.1182/blood.V110.11.251.251

Published: 2007

Journal Articles

The Myocyte Enhancer Factor 2C ( MEF2C ) Is a Direct Transcriptional Target of HOXA9 and Mediates Leukemia Survival in Human Mixed-Lineage Leukemias.

Jorg Faber, MD, PhD, Andrei V. Krivstov, PhD, Matthew C. Stubbs, PhD, Marry van den Heuvel-Eibrink, MD, PhD, Andrew L. Kung, MD, PhD, Christian M. Zwaan, MD, PhD, Scott A. Armstrong, MD, PhD

Blood (2007) 110 (11): 58.

https://doi.org/10.1182/blood.V110.11.58.58

Published: 2007

Journal Articles

HoxA9 Knockdown Inhibits Proliferation and Induces Cell Death in Human MLL-Rearranged Leukemias.

Jorg Faber, MD, PhD, Andrei V. Krivtsov, PhD, Matthew C. Stubbs, PhD, Renee Wright, Marry van den Heuvel-Eibrink, MD PhD, Andrew L. Kung, MD PhD, Christian M. Zwaan, MD PhD, Scott A. Armstrong, MD PhD

Blood (2006) 108 (11): 734.

https://doi.org/10.1182/blood.V108.11.734.734

Published: 2006

Journal Articles

Monosomy 7 and Deletion 7q in Childhood AML. A Collaborative Study of 20 Study Groups.

Blood (2004) 104 (11): 402.

https://doi.org/10.1182/blood.V104.11.402.402

Published: 2004

NARROW

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group

The miRNA-193 Family Is a Potent Tumor-Suppressor and a Biomarker for Poor Prognosis in Acute Myeloid Leukemia

Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

IKZF1 deletions in Pediatric Acute Myeloid Leukemia

ETV6 Aberrations Are a Recurrent Event in Pediatric Acute Myeloid Leukemia with Poor Clinical Outcome

Microrna-106b~25 Cluster Is Involved in Relapsed MLL -Rearranged Pediatric AML

Clinical Impact of Additional Cytogenetic Aberrations and Complex Karyotype In Pediatric 11q23/ MLL -Rearranged AML: Results from an International Retrospective Study

High IGSF4 expression In Pediatric Acute Monoblastic Leukemia with t(9;11)

Refractory Cytopenia In Childhood (RCC) with Normal Karyotype Is Unlikely to Progress to Advanced MDS Under a Watch and Wait Strategy

HOXA9 is required for survival in human MLL -rearranged acute leukemias

A Complex Karyotype but Not Monosomy 7 Is an Independent Prognostic Factor in Advanced Childhood MDS.

Hematopoietic Stem Cell Transplantation (HSCT) after a Myeloablative Conditioning Regimen in Children with Refractory Cytopenia (RC): Results of a Retrospective Analysis from the EWOG-MDS Group.

The Myocyte Enhancer Factor 2C ( MEF2C ) Is a Direct Transcriptional Target of HOXA9 and Mediates Leukemia Survival in Human Mixed-Lineage Leukemias.

HoxA9 Knockdown Inhibits Proliferation and Induces Cell Death in Human MLL-Rearranged Leukemias.

Monosomy 7 and Deletion 7q in Childhood AML. A Collaborative Study of 20 Study Groups.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only